Qingdao Baheal Medical Inc
SZSE:301015
Wall Street
Price Targets
Price Targets Summary
Qingdao Baheal Medical Inc
According to Wall Street analysts, the average 1-year price target for Qingdao Baheal Medical Inc is 52.02 CNY with a low forecast of 51.51 CNY and a high forecast of 53.55 CNY.
Operating Income
Forecast
Operating Income Estimate
Qingdao Baheal Medical Inc
For the last 3 years the compound annual growth rate for Qingdao Baheal Medical Inc's operating income is 30%. The projected CAGR for the next 3 years is 28%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Qingdao Baheal Medical Inc's stock price target?
Price Target
52.02
CNY
According to Wall Street analysts, the average 1-year price target for Qingdao Baheal Medical Inc is 52.02 CNY with a low forecast of 51.51 CNY and a high forecast of 53.55 CNY.
What is Qingdao Baheal Medical Inc's Revenue forecast?
Projected CAGR
12%
For the last 3 years the compound annual growth rate for Qingdao Baheal Medical Inc's revenue is 16%. The projected CAGR for the next 3 years is 12%.
What is Qingdao Baheal Medical Inc's Operating Income forecast?
Projected CAGR
28%
For the last 3 years the compound annual growth rate for Qingdao Baheal Medical Inc's operating income is 30%. The projected CAGR for the next 3 years is 28%.
What is Qingdao Baheal Medical Inc's Net Income forecast?
Projected CAGR
31%
For the last 3 years the compound annual growth rate for Qingdao Baheal Medical Inc's net income is 34%. The projected CAGR for the next 3 years is 31%.